camptothecin has been researched along with benzoxazoles in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Gatto, B; Kim, JS; LaVoie, EJ; Liu, A; Liu, LF; Sun, Q; Yu, C | 1 |
| Culmsee, CW; Cutler, RG; Greig, NH; Holloway, HW; Lahiri, DK; Mattson, MP; Yu, QS; Zhu, X | 1 |
| Arlt, A; Ceyhan, GO; Dantes, Z; Feuerecker, B; Hassan, Z; Knauer, SK; Krämer, OH; Rad, R; Reichert, M; Saur, D; Schmid, RM; Schneeweis, C; Schneider, G; Stauber, R; Veltkamp, C; Weichert, W; Wirth, M | 1 |
3 other study(ies) available for camptothecin and benzoxazoles
| Article | Year |
|---|---|
Structure-activity relationships of benzimidazoles and related heterocycles as topoisomerase I poisons.
Topics: Antineoplastic Agents, Phytogenic; Benzimidazoles; Benzoxazoles; Camptothecin; Cell Line; DNA Damage; DNA Topoisomerases, Type I; Dose-Response Relationship, Drug; Humans; Structure-Activity Relationship; Topoisomerase I Inhibitors | 1996 |
Novel p53 inactivators with neuroprotective action: syntheses and pharmacological evaluation of 2-imino-2,3,4,5,6,7-hexahydrobenzothiazole and 2-imino-2,3,4,5,6,7-hexahydrobenzoxazole derivatives.
Topics: Animals; Apoptosis; Benzoxazoles; Camptothecin; Culture Techniques; Hippocampus; Imines; Ischemic Attack, Transient; Neuroprotective Agents; PC12 Cells; Rats; Rats, Sprague-Dawley; Structure-Activity Relationship; Thiazoles; Transcription Factors; Tumor Suppressor Protein p53 | 2002 |
MTOR inhibitor-based combination therapies for pancreatic cancer.
Topics: Animals; Antineoplastic Agents; Benzoxazoles; Bortezomib; Camptothecin; Carcinoma, Pancreatic Ductal; Cell Line, Tumor; Cell Survival; Extracellular Signal-Regulated MAP Kinases; Humans; MAP Kinase Signaling System; Mechanistic Target of Rapamycin Complex 1; Mechanistic Target of Rapamycin Complex 2; Mice; Pancreatic Neoplasms; Phosphatidylinositol 3-Kinase; Proto-Oncogene Proteins c-akt; Pyrimidines; TOR Serine-Threonine Kinases | 2018 |